Internal Medicine Alert – September 15, 2019
September 15, 2019
View Issues
-
Atorvastatin: What Is Good for the Heart Is Good for the Kidneys
For patients at risk of or who already have been diagnosed with cardiovascular disease and are taking atorvastatin, an added benefit is improved kidney function in a dose-dependent manner.
-
Reducing Mortality in Stable Ischemic Heart Disease Patients
A multivariate analysis of a large registry of patients with stable ischemic heart disease revealed that beta-blocker use was associated with lower mortality only when prescribed in the first year after acute myocardial infarction.
-
Hot Beverages and Esophageal Cancer
In a cohort of more than 50,000 people, there was a higher risk of esophageal squamous cell carcinoma in those who consumed higher quantities of mostly black tea at hotter temperatures.
-
Imipenem, Cilastatin, and Relebactam Injection (Recarbrio)
The FDA has approved a new antibacterial drug combination for complicated urinary tract infections and complicated intra-abdominal infections.
-
Are the Changes New, Recent, or Old?
Imagine examining the ECG in the figure below without any accompanying clinical information. How would one interpret this tracing? What might one suspect is going on?